Pathogenesis of hyperthyroïdism;Données récentes sur la Physiopathologie des hyperthyroïdies

Bulletin de l'Academie Nationale de Medecine

Volumn 187, Issue 4, 2003, Pages 671-682

  Milgrom, Edwin ^a  

^a BICÊTRE HOSPITAL   (France)

Author keywords

Antibodies; Gprotein; Graves' diseases; Hyperthyroidism; Receptors; Stimulatory Gsautoimmune diseases; Thyrotropin

Indexed keywords

AUTOANTIBODY; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; THYROTROPIN RECEPTOR;

ANIMAL; ANTIBODY SPECIFICITY; AUTOIMMUNE DISEASE; GENETICS; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; IMMUNOLOGY; MOUSE; MUTATION; PATHOPHYSIOLOGY; REVIEW;

ANIMALS; ANTIBODY SPECIFICITY; AUTOANTIBODIES; AUTOIMMUNE DISEASES; GRAVES DISEASE; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HUMANS; HYPERTHYROIDISM; MICE; MUTATION; RECEPTORS, THYROTROPIN;

EID: 84888112073     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)33998-6     Document Type: Article

References (41)

1. BARTELS E.D. - Heredity in Graves' disease - Munksgaard: Copenhagen, 1941.
2. AHO K., GORDIN A., SIEVERS K. TAKALA J. - Thyroid autoimmunity in siblings: a population study. Acta. Endocrinol. (Copenh), 1983, 251, 11-15.
3. STBNSZKY V., KOZMA L., BALAZS C, ROCHLITZ S., BEAR J.C., FARID N.R, - The genetics of Graves' disease: HLA and disease susceptibility. J. Clin. Endocrinol. Metok, 1985, 61(4), 735-740.
4. ALLANIC H., FAUCHET R., LORCY Y., HEIM J., GUBGUEN M., LEGUERRIER A.M., GENETET B. - HLA and Graves' disease: an association with HLA-DRw3. J. Clin. Endocrinol. Metab, 1980, 51(4), 863-867.
5. PAYAMI H., JOE S., FARID NR, STBNSZKY V., CHAN S.H., YEO P.P., CHEAH J.S., THOMSON G. - Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves disease. Am. J. Hum. Genet., 1989, 45, 541-546.
6. SHIELDS DC, RATANACHAIYAVONG S., MCGREGOR A.M., COLLINS A., MORTON N.E. - Combined segregation and linkage analysis of Graves' disease with a thyroid autoantibody diathesis. Am. J. Hum. Genet., 1994, 55, 540-554.
7. HEWARD J.M., ALLAHABADIA A., ARMITAGE M., HATTERSLEY A., DODSON P.M., MACLEOD K., CARR-SMITH X, DAYKIN X, DALY A., SHEPPARD M.C, HOLDER R.L., BARNETT A.H., FRANKLYN J.A., GOUGH S.C.L. - The development of Graves' disease and the CTLA-4 gene on chromosome 2q33 J. Clin. Endocrinol. Metab, 1999, 84(7), 2398-2401.
8. GROSS B., MISRAHI M., SAR S., MILGROM E. - Composite structure of the human thyrotropin receptor gene. Biochem. Biophys. Res. Commun., 1991, 177, 679-687.
9. BAHN R.S., DUTTON CM, HEUFELDER A.E., SARKAR G. - A genomic point mutation in the extracellular domain of the thyrotropin receptor in patients with Graves' ophtalmopathy. J. Clin. Endocrinol. Metok, 1994, 78, 256-260.
10. WATSON P.E, FRENCH A., PICKERILL A.P., MCINTOSH R.S., WEETMAN A.P. - Lack of association between a polymorphism in the coding region of the thyrotropin receptor gene and Graves' disease. J. Clin. Endocrinol. Metok, 1995, 80, 1032-1035.
11. CUDDIHY R.M., DUTTON C.M., BAHN R.S. - A polymorphism in the extracellular domain of the thyrotropin receptor is highly associated with autoimmune thyroid disease in females. Thyroid., 1995, 5, 89-95.
12. DE ROUX N., SHIELDS D.C., MISRAHI M., RATANACHAIYAVONG S., MCGREGOR A.M., MILGROM E. - Analysis of the thyrotropin receptor as a candidate gene in familial Graves' disease. J. Clin. Endocrinol. Metab, 1996, 81(10), 3483-3486.
13. LOOSFELT H., PICHON C, JOLIVET A., MISRAHI M., CAILLOU B., JAMOUS M., VANNIER B., MILGROM E. - Two subunit structure of the human TSH receptor. Proc. Natl. A cad. Sci., 1992, 89, 3765-3769.
14. DE BERNARD S., MISRAHI M., HUET J.C., BEAU I., DESROCHES A., LOOSFELT H., PICHON G, PERNOLLET J.G, MILGROM E. - Sequential cleavage and excision of a segment of the thyrotropin receptor ectodomain. J. Biol. Chem., 1999, 274, 101-107.
15. CHISTYAKOV D.A., SAVOST'ANOV K.V., TURAKULOV R.I., NOSIKOV V.V. - Genetic determinants of Graves disease. Mol Genet. and Metab, 2000, 71, 66-69.
16. VAIDYA B., IMRIE H., PBRROS P., YOUNG E.T., KELLY W.F., CARR D., LARGE D.M., TOFT A.D., KENDALL-TAYLOR P., PEARCE S.H.S. - Evidence for a new Graves disease susceptibility locus at chromosome 18q21. Am. J. Hum. Genet., 2000, 66, 1710-1714.
17. TOMER Y., DAVIES T.F. - The genetic susceptibility to Graves' disease. Baillieres Clin. Endocrinol Metab., 1997, 11 (3), 431-450.
18. PHILIPPOU G, MCGREGOR A.M. - The aetiology of Graves' disease: what is the genetic contribution? Clin. Endocrinol., 1998, 48, 393-395.
19. GOUGH S.C.L. - The genetics of Graves' disease. Endocrinol. Metab. Clin. North Am., 2000, 29(2), 255-266.
20. REES SMITH B., MCLACHLAN S.M., FURMANIAK J. - Autoantibodies to the thyrotropin receptor. Endocr. Rev., 1988, 9, 106-121.
21. WEETMAN A.P., MCGREGOR A.M. - Autoimmune thyroid disease: further developments in our understanding. Endocr. Rev., 1994, 15, 788-830.
22. COSTAGLIOLA S., MORGENTHALER N.G, HOERMANN R., BADENHOOP K., STRUCK J., FREITAG D., POERTL S., WEGLÖHNER W, HOLLIDT J.M., QUADBECK B., DUMONT J.E., SCHUMM-DRAEGER P.M., BERGMANN A., MANN K., VASSART G., USADEL K.H. - Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease. J. Clin. Endocrinol. Metab., 1999, 84(1), 90-97.
23. KAKINUMA A., MORIMOTO I., KURODA T., FUJIHIRA T., ETO S., MCLACHLAN S.M., RAPOPORT B. - Comparison of recombinant human thyrotropin receptors versus porcine thyrotropin receptors in the thyrotropin binding inhibition assay for thyrotropin receptor autoantibodies. Thyroid, 1999, 9(9), 849-855.
24. TAHARA K., ISHIKAWA N., YAMAMOTO K., HIRAJ A., ITO K., TAMURA Y, YOSHHIDA S., SAITO Y., KOHN L.D. - Epitopes for thyroid stimulating and blocking autoantibodies on the extracellular domain of the human thyrotropin receptor. Thyroid, 1997, 7, 867-877.
25. SCHWARZ-LAUER L., CHAZENBALK G.D., MCLACHLAN S.M., OCHI Y., NAGAYAMA Y, RAPOPORT B. - Evidence for a simplified view of autoantibody interactions with the thyrotropin receptor. Thyroid, 2002, 12(2), 115-120.
26. COSTAGLIOLA S., RODiEN P., MANY M.C., LUDGATE M., VASSART G. - Genetic immunization against the human thyrotropin receptor causes thyroiditis and allows production of monoclonal antibodies recognizing the native receptor. J. Immunol, 1998, 160, 1458-1465.
27. SHIMOJO N., KOHNO Y, YAMAGUCHI K.J., KIKUOKA S., HOSHIOKA A., NHMI H., HIRAI A., TAMURA Y., SAITO Y, KOHN L.D. TAHARA K. - Induction of Graves-like disease in mice by immunization with fibroblasts transfected with the thyrotropin receptor and a class II molecule. Proc. Natl Acad. Sci. USA, 1996, 93(20), 11074-11079.
28. YAMAGUCHI K.I., SHIMOJO N., KIKUOKA S., HOSHIOKA A., HIRAI A., TAHARA K., KOHN L.D., KOHNO Y, NIIMI H. - Genetic control of anti-thyrotropin receptor antibody generation in H-2k mice immunized with thyrotropin receptor-transfected fibroblasts. J. Clin Endocrinol Metab., 1997, 82 (12), 4266-4269.
29. KAITHAMANA S., FAN J., OSUGA Y, LIANG S.G., PRABHAKAR B.S. - Induction of experimental autoimmune Graves' disease in BALB/c mice. J. Immunol, 1999, 163, 5157-5164.
30. ATGER M., MISRAHI M., YOUNG J., JOUVET A., ORGIAZZI J., SCHAISON G, MILGROM E. - Autoantibodies interacting with purified native thyrotropin receptor. Eur. J. Biochem., 1999, 265, 1022-1031.
31. Editorial: Pathogenesis of Graves' ophtalmopathy - current understanding. J. Clin. Endocrinol. Metab., 2001, 86(2), 501-503.
32. DAUMERIE G, LUDGATE M., COSTAGLIOLA S., MANY M.C. - Evidence for thyrotropin receptor immunoreactivity in pretibial connective tissue from patients with thyroid-associated dermopathy. Eur J. Endocrinol, 2002, 146 (1), 35-8.
33. DUPREZ L., PARMA J., VAN SANDE J., RODIEN P., DUMONT J.E., VASSART G., ABRAMOWICZ M. - TSH receptor mutations and thyroid disease. TEM, 1998, 9(4), 133-140.
34. MURAKAMI M., KAMIYA Y, YANAGITA Y., MORI M. - Gsα mutations in hyperfunctioning thyroid adenomas. Arch. Med. Res., 1999, 30, 514-521.
35. TRÜLZSCH B., NEBEL T., PASCHKE R. - The thyrotropin receptor mutation database. Thyroid, 1999, 9(6), 521-522.
36. KHOO D.H., PARMA J., RAJASOORYA C, HO S.C., VASSART G - A germline mutation of the thyrotropin receptor gene associated with thyrotoxicosis and mitral valve prolapse in a chinese family. J. Clin. Endocrinol. Metah, 1999, 84(4), 1459-1462.
37. DE ROUX N., POLAK M., COUET J., LEGER J., CZERNICHOW P., MILGROM E., MISRAHI M. - A neomutation of the Thyroid-Stimulating Hormone receptor in a severe neonatal hyperthyroidism. J. Clin. Endocrinol. Metab., 1996, 81(6), 2023-2026.
38. DUMONT J.E., JAUNIAUX J.C., ROGER P.P. - The cAMP-mediated stimulation of cell proliferation. Trends Biochem. Sci., 1989, 14(2), 67-71.
39. TONACCHERA M., AGRETTI P., CHIOVATO L., ROSELLINI V., CECCARINI G, PERRI A., VIACAVA P., NACCARATO A.G., MICCOLI P., PINCHERA, A. VITTI P. - Activating thyrotropin receptor mutations are present in nonadenomatous hyperfunctioning nodules of toxic or autonomous multinodular goiter. J. Clin. Endocrinol. Metab., 2000, 85(6), 2270-2274.
40. Russo D., ARTURI F., SCHLUMBERGER M., CAILLOU B., MONIER R., FILETTI S., SUAREZ H.G. - Activating mutations of the TSH receptor in differentiated thyroid carcinomas. Oncogene, 1995, 11(9), 1907-1911.
41. CAMACHO P., GORDON D., CHIEFARI E., YONG S., De JONG S., PITALE S., RUSSO D., FILETTI S. - A Phe 486 thyrotropin receptor mutation in an autonomously functioning follicular carcinoma that was causing hyperthyroidism. Thyroid, 2000, 10(11), 1009-1012.